JESSICA ROYCE: Open Payments
NPI 1609244383 · MILTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,132 in 53 payments from 14 companies in 2025. Trend: 2023 $806 · 2024 $864 · 2025 $1,132
Food & beverage: $1,132
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $292 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $182 |
| PFIZER INC. | 6 | $129 |
| ABBVIE INC. | 4 | $89 |
| Novo Nordisk Inc | 5 | $84 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $69 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $65 |
| Amgen Inc. | 4 | $65 |
| SHIELD THERAPEUTICS INC | 2 | $39 |
| Lilly USA, LLC | 2 | $37 |
Products named: AIRSUPRA, Kerendia, Ozempic, FARXIGA, QULIPTA, XIFAXAN, ELIQUIS, LUMRYZ.
Industry payments across FL — which companies pay providers there.
